High Throughput Screening (HTS) Market Worth $19,626.54 Million by 2018
DALLAS, February 4, 2014
DALLAS, February 4, 2014 /PRNewswire/ --
According to the new market research report, the " High Throughput Screening
(HTS) Market by Technology (Cell Based, Ultra High Throughput Screening
(UHTS), Label Free, Bioinformatics), by Applications (Target
Identification, Primary Screening , Toxicology, Stem Cell), by End Users
(Pharmaceutical Industry , Biotechnology Industry , CRO) - Forecast to
2018 ", analyzes and studies the major market drivers, restraints, and
opportunities in North America, Europe, Asia, and Rest of the World.
Browse 75 tables and 23 figures spread through 245 pages and in-depth TOC on
"High Throughput Screening (HTS) Market".
Early buyers will receive 10% customization on this report.
This report studies the global high throughput screening (HTS) market over the
forecast period of 2013 to 2018. The global HTS market was valued at an
estimated $13,735.88 million in 2013 and is poised to grow at a CAGR of 7.4%
from 2013 to 2018, to reach $19,626.54 million by 2018.
A number of factors such as technological innovations, open innovation models
adopted by pharmaceutical companies, increasing drug discovery initiatives by
academic institutions, and huge capital investments in the HTS technology by
organizations are driving the growth of the HTS market. Moreover, the presence
of a large untapped market in emerging countries and the incessant rise in
outsourced drug discovery services especially in China and India are the
various growth opportunities in this market. However, the capital intensive
nature of HTS and difficulties in assay development for novel target classes
are the factors that are curbing the growth of this market.
The HTS Market is broadly classified into five segments, namely, technology,
products, applications, end users, and geography. In the applications segment,
the target identification market held the largest share of 45% in 2013. The
availability of large compound libraries and well-equipped HTS laboratories,
and technological advancements are the major factors driving the growth of
this market. However, the primary screening market is poised to grow at the
highest CAGR. The availability of a large number of potential lead compounds,
emergence of several new detection technologies, and availability of novel
primary and stem cell phenotypes are the factors that are responsible for the
growth of this market segment. The growth in the outsourcing of drug services,
especially in the Asian region, is a major reason for the high growth of the
HTS market. In the end-users market, the pharmaceuticals segment dominated the
market in 2013, with a market share of around 45%. In the technology market,
the label-free technology segment is expected to register the highest growth
in the forecast period. Label-free technology offers the direct detection
ability, which was not possible with cell-based assays. Furthermore, it helps
in reducing drug failure due to toxicity and can be applied to a majority of
The global High Throughput Screening Market is dominated by North America,
followed by Europe, Asia, and the Rest of the World (RoW). The large market
share of the North American region is attributed to the increased investments
by drug discovery firms for the promotion and advancement of technologies and
increasing number of collaborations among companies and academia to develop
and distribute innovative HTS products.
The major players in the HTS market include Agilent Technologies (U.S.),
PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher
Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.), and Tecan group
(Switzerland), among others.
Browse related reports
In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management
Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics,
Haematology) & Applications (Diabetes, Infectious Diseases, Cancer &
Cardiology)] Systems, End Users] - Forecast To 2017
Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals
(Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis)
Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends &
Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in
the U.S. We publish strategically analyzed market research reports and serve
as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles,
databases, and custom research services. MarketsandMarkets covers thirteen
industry verticals; including advanced materials, automotives and
transportation, banking and financial services, biotechnology , chemicals,
consumer goods, telecommunications and IT, energy and power, food and
beverages, industrial automation, medical devices,
pharmaceuticals,agriculture industry, semiconductor and electronics,
aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
Contact: Mr.Rohan North - Dominion Plaza 17304 Preston Road Suite
800,Dallas, TX75252 Tel: +1-888-600-6441 Email: firstname.lastname@example.org
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @
Press spacebar to pause and continue. Press esc to stop.